Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

OCUL holding history

Ocular Therapeutix, Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OCUL overviewAll 13F holders of OCULFull Q2 2026 holdings

Shares (Q2 2026)
1,551,001
Value
$15.2M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of OCUL by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,551,001$15.2M<0.1%+30,370+2.0%AddedHolders
Q1 20261,520,631$12.9M<0.1%+275,687+22.1%AddedHolders
Q4 20251,244,944$15.1M<0.1%−3,322−0.3%ReducedHolders
Q3 20251,248,266$14.6M<0.1%−716,885−36.5%ReducedHolders
Q2 20251,965,151$18.2M<0.1%+630,212+47.2%AddedHolders
Q1 20251,334,939$9.79M<0.1%+458,393+52.3%AddedHolders
Q4 2024876,546$7.49M<0.1%+191,770+28.0%AddedHolders
Q3 2024684,776$5.96M<0.1%−63,957−8.5%ReducedHolders
Q2 2024748,733$5.12M<0.1%+265,227+54.9%AddedHolders
Q1 2024483,506$4.40M<0.1%+392,673+432.3%AddedHolders
Q4 202390,833$405.1K<0.1%+37,259+69.5%AddedHolders
Q3 202353,574$168.2K<0.1%−76,377−58.8%ReducedHolders
Q2 2023129,951$670.5K<0.1%+128,674+10,076.3%AddedHolders
Q1 20231,277$6.73K<0.1%00.0%UnchangedHolders
Q4 20221,277$3.59K<0.1%+277+27.7%AddedHolders
Q3 20221,000$4.00K<0.1%−341,228−99.7%ReducedHolders
Q2 2022342,228$1.38M<0.1%+307,344+881.0%AddedHolders
Q1 202234,884$173.0K<0.1%−60,006−63.2%ReducedHolders
Q4 202194,890$661.0K<0.1%−231,738−70.9%ReducedHolders
Q3 2021326,628$3.27M<0.1%−258,165−44.1%ReducedHolders
Q2 2021584,793$8.29M<0.1%+33,929+6.2%AddedHolders
Q1 2021550,864$9.04M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.